Home301333 • SHE
add
R&G PharmaStudies Co Ltd
Previous close
¥54.51
Year range
¥40.99 - ¥72.38
Market cap
5.29B CNY
Avg Volume
2.91M
P/E ratio
34.17
Dividend yield
0.29%
Primary exchange
SHE
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 227.71M | 24.48% |
Operating expense | 38.00M | -11.56% |
Net income | 34.45M | 32.98% |
Net profit margin | 15.13 | 6.85% |
Earnings per share | — | — |
EBITDA | 38.49M | 24.09% |
Effective tax rate | 10.56% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.72B | -0.95% |
Total assets | 2.32B | 0.95% |
Total liabilities | 394.86M | -22.58% |
Total equity | 1.93B | — |
Shares outstanding | 95.14M | — |
Price to book | 2.70 | — |
Return on assets | 3.95% | — |
Return on capital | 4.75% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 34.45M | 32.98% |
Cash from operations | -1.24M | -102.80% |
Cash from investing | -100.82M | -168.15% |
Cash from financing | -9.58M | 61.18% |
Net change in cash | -112.84M | -168.14% |
Free cash flow | -38.11M | 39.37% |
About
Founded
Aug 22, 2008
Website
Employees
2,208
